Xcelience formulation development expertise helps clients to move drug candidates forward faster and to maximize the chance for compound success.
Our formulation development capabilities include pharmaceutical formulation development for NDA and ANDA dosage forms, excipient compatibility studies, troubleshooting and process development of existing dosage forms, optimization of existing drug formulations, and qualitative / quantitative evaluation of proprietary dosage forms. For more information, see the list of our pharmaceutical formulation capabilities below, or click on “get a solution” above and one of our experts will contact you personally to help you come up with the perfect drug formulation solution.
We offer dosage form expertise for:
- Solids
- tablets (immediate release, modified release, sustained release, chewable lozenge)
- capsules (hard gelatin, granulated or dilution blend)
- direct compression, dry and wet granulation, bead coating, and lyophilization
- Semi-Solids (oral, mucosal, topical)
- emulsions and micro-emulsions
- gels (aqueous, non-aqueous)
- lipid solutions
- suspensions
- Oral Liquids
- development of dosage forms and preservative systems
- development, optimization and lyophilization
- Topicals
- creams
- ointments
- gels
- solutions
- lotions
Formulation development services include:
- Physical testing of powders – bulk and tap density, particle size analysis (laser diffraction or sonic sifter)
- Physical testing of solids – weight variation, thickness, hardness, friability, disintegration
- Solutions, Semi-solid testing – osmolality, pH viscibility, sedimentation, viscosity, brookefield RVOVII, rheometer